Zoek een onderzoeksproject
Andere zoekoptie(s)
49 Resultaat/Resultaten
Beëindigde onderzoeksprojecten = 
Gefinancierd door een IRDiRC-lid = 
Lid van een ERN = 
Onderzoeksprojecten
FRANKRIJK
ILE-DE-FRANCE
PARIS
Oncogenetics of digestive diseases: medical approach of familial forms
AP-HP.Centre - Université de Paris - Hôpital Cochin
Gastro-entérologie et oncologie digestive
BELGIË
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up van de vruchtbaarheid bij jongvolwassenen die het testisweefsel wel of niet hebben opgeslagen vóór de gonadotoxische behandeling voor het behoud van de vruchtbaarheid
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)
CANADA
Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute
DUITSLAND
Baden-Württemberg
FREIBURG
MTB-FR: Register study of the Molecular Tumor Board (tumor entity-spanning molecular characterization program to evaluate individualized tumor biology-guided therapy in adults with rare and advanced tumor entities
Universitätsklinikum Freiburg
Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation
DUITSLAND
Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg
DUITSLAND
Baden-Württemberg
MANNHEIM
Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
Universitätsmedizin Mannheim
Kinderchirurgische Klinik
DUITSLAND
Bayern
AUGSBURG
CancerEvo: Investigation of evolution in sporadic and tumor disposition syndrome-associated tumors
Universitätsklinikum Augsburg
II. Medizinische Klinik
ITALIË
VENETO
PADOVA
Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS
OOSTENRIJK
WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT
OOSTENRIJK
WIEN
WIEN
PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH
OOSTENRIJK
WIEN
WIEN
Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
OOSTENRIJK
WIEN
WIEN
Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT
St. Anna Kinderkrebsforschung
USA
Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US
USA
Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US
USA
Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US
DUITSLAND
Hamburg
HAMBURG
KFO 306: Primary sclerosing cholangitis
UKE - Universitätsklinikum Hamburg-Eppendorf
I.Medizinischen Klinik und Poliklinik
DUITSLAND
Niedersachsen
GÖTTINGEN
PALL-CCC: Retrospective analysis of palliative second-line chemotherapy in cholangiocarcinoma patients
Universitätsmedizin Göttingen
Klinik für Gastroenterologie, gastrointestinale Onkologie und Endokrinologie
DUITSLAND
Niedersachsen
HANNOVER
Optimizing molecular and immunotherapies for the treatment of cholangiocarinoma
Medizinische Hochschule Hannover
Klinik für Gastroenterologie, Hepatologie und Endokrinologie
OOSTENRIJK
WIEN
ADDRESS: NOT PROVIDED - AT
EURO-CHOLANGIO-NET: European Cholangiocarcinoma Network - AT
Institution: Information not provided - AT
SPANJE
Andalucía
HUELVA
QuiCo: Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center -ES
Hospital Juan Ramón Jiménez
Servicio de Cirugía General
SPANJE
Madrid
MADRID
Mechanistic models using Machine Learning for therapeutic targets discovery and drug repurposing in Rare Diseases
ISCIII - Instituto de Salud Carlos III
Centro de Investigación Biomédica en Red de Enfermedades Raras
USA
Maryland
BETHESDA
Npc/mipe toxicity screen of idh1 inhibitors against cholangiocarcinoma cell lines
National Center for Advancing Translational Sciences (NCATS-NIH)
Informatics
DUITSLAND
Baden-Württemberg
MANNHEIM
Survey on the choice of therapeutic strategy for hepatocellular carcinoma (HCC)
Universitätsmedizin Mannheim
Chirurgische Klinik
DUITSLAND
Bayern
WÜRZBURG
Targeting MYC-driven hepatocellular carcinoma via Aurora-A ligands (FOR 2314: Targeting therapeutic windows in essential cellular processes for tumor therapy)
Universität Würzburg - Biozentrum
Lehrstuhl für Biochemie und Molekularbiologie
DUITSLAND
Berlin
BERLIN
ImmuMITT: Immunological Effects Of Minimally Invasive Therapies In Patients With Hepatocellular Carcinoma
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Radiologie
DUITSLAND
Niedersachsen
HANNOVER
TRR 209: Liver Cancer - New mechanistic and therapeutic concepts in a solid tumor mode l- Project C6: Targeting the mutanome of liver cancer by viral oncoly-sis and tumor-directed immunotherapies
Medizinische Hochschule Hannover
Klinik für Gastroenterologie, Hepatologie und Endokrinologie
DUITSLAND
Niedersachsen
HANNOVER
TRR 209: Liver Cancer - New mechanistic and therapeutic concepts in a solid tumor mode l- Project C07: Identification of molecular mechanisms conferring resistance to oncolytic viruses in HCC and implications for successful HCC virotherapy
Medizinische Hochschule Hannover
Klinik für Gastroenterologie, Hepatologie und Endokrinologie
FRANKRIJK
BRETAGNE
RENNES
Impact of phenotypic fluidity in the heterogeneity and progression of hepatocellular carcinoma
Institut NuMeCan
Exogenous and Endogenous Stress and Pathological Responses in Hepato-Gastrointestinal Diseases
FRANKRIJK
OCCITANIE
MONTPELLIER
Role of the P53 pathway in lipid metabolism: implications in liver function and hepatocellular carcinoma development
Institut de Recherche en Cancérologie de Montpellier
Molecular oncogenesis
OOSTENRIJK
WIEN
WIEN
Role of Axl Receptor Shedding in Liver Cancer
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie
OOSTENRIJK
WIEN
WIEN
REFINE: Regorafenib Observational Study in Hepatocellular Carcinoma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Gastroenterologie und Hepatologie
USA
Washington
ADDRESS: NOT PROVIDED - US
Prkaca for fibrolamellar hepatocellular carcinoma
Institution: Information not provided - US
USA
Washington
ADDRESS: NOT PROVIDED - US
The role of carboxypeptidase e in cancer
Institution: Information not provided - US
USA
Washington
ADDRESS: NOT PROVIDED - US
Targeting understudied kinases in cancer cell plasticity and drug resistance
Institution: Information not provided - US
ZWITSERLAND
Suisse Alémanique
BASEL
The role of the inflammatory microenvironment in liver cancer development
Universitätsspital Basel
Institut für Pathologie
ZWITSERLAND
Suisse Alémanique
ZÜRICH
Exploring the molecular mechanism of HIF-2alpha-mediated pexophagy to identify novel therapeutic targets for the treatment of clear cell renal cell carcinoma (ccRCC) and hepatocellular carcinoma (HCC)
ETH Zürich
Molekulare Gesundheitswissenschaften Departement Biologie
CANADA
Québec
ADDRESS: NOT PROVIDED - CA
Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility
Institution: Information not provided - CA
OOSTENRIJK
WIEN
ADDRESS: NOT PROVIDED - AT
STELLAR: A Multicentre, Observational, Phase 4 Study to Evaluate the Safety and Tolerability of Lenvatinib in Patients With Advanced or Unresectable Hepatocellular Carcinoma - AT
Institution: Information not provided - AT
SPANJE
Andalucía
GRANADA
A Single Center Experience: Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With Early and Intermediate HCC
Hospital Universitario Virgen de las Nieves
Servicio de Radiodiagnóstico
Multicentrische onderzoeksprojecten
- UMCG - Universitair Medisch Centrum Groningen
- Afdeling Genetica
- Institution: Information not provided - DE
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine
- Leibniz Research Centre for Working Environment and Human Factors
- Department of Toxicology/Systems Toxicology
- Institution: Information not provided - IT
NEDERLAND
Groningen
GRONINGEN
MMR-RELATED CANCER: prevention, diagnosis and molecular characterisation of mismatch repair defect-related hereditary cancers of the digestive system
DUITSLAND
Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Targeting Of Resistance in PEDiatric Oncology
ITALIË
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities
ITALIË
LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe
ITALIË
LOMBARDIA
MILANO
RARECARENet: Information network on rare cancers
OOSTENRIJK
WIEN
WIEN
ExPO-r-Net: European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment
VERENIGD KONINKRIJK
Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium
FRANKRIJK
ILE-DE-FRANCE
ORSAY
CAMINEMS: Integrated Micro-Nano-Opto Fluidic systems for high-content diagnosis and studies of rare cancer cells
DUITSLAND
Bayern
DORTMUND
CANCERSYS: Mathematical modelling of beta-catenin and ras signalling in liver and its impact on proliferation, tissue organization and formation of hepatocellular carcinomas
ITALIË
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT